Vitamin D: uses, evidence, dosing and safety

Vitamin D is the most heavily researched supplement in existence, and the research keeps arriving at the same place.

If you are short of it, correcting that helps. If you are not short of it, taking more does very little, and this page covers thirteen separate areas where that has now been tested.

What vitamin D is

Vitamin D is a fat-soluble vitamin, meaning it dissolves in fat rather than water. That has a practical consequence stated in the same reference: fat-soluble vitamins are stored in the body’s fatty tissue and liver, so unlike vitamin C it accumulates rather than washing out.

Its best-established job is not glamorous. Vitamin D helps the body absorb calcium, and calcium is a mineral that you must have for normal bone formation.

The form measured in blood is called 25-hydroxyvitamin D, which is why a test result carries that name rather than plain vitamin D.

How vitamin D works

Sunlight on skin starts it. The body then converts it twice, once in the liver and once in the kidney, into the active hormone that acts on the gut, bone and a great many other tissues.

Two features of that pathway explain most of this page.

The first is that receptors for it appear almost everywhere in the body, which is why researchers keep testing it against almost everything. The second is that the system is regulated: once there is enough to do the job, more raw material does not produce more effect. That is the shape of nearly every result below.

What the evidence says about vitamin D and bone

This is the use with the strongest rationale and, awkwardly, one of the clearest negative answers.

A 2026 review in the BMJ, the British Medical Journal, examined calcium, vitamin D, or combined supplementation to prevent fractures and falls. Its conclusion, based on absolute risk reductions and thresholds considered clinically meaningful, is that it found little to no benefits on either.

The certainty attached is what makes this hard to argue with. The review reports that its findings were based largely on moderate to high certainty of evidence, and that they remained robust after an extensive exploration of heterogeneity.

One caveat the reviewers name themselves: evidence for high risk patients or those requiring residential care was limited for several outcomes. Nobody is saying a frail, housebound, genuinely deficient person gains nothing. The claim is about supplementing the general population.

What the evidence says about vitamin D and respiratory infections

The immunity claim is the second-biggest reason people buy it, and it has the largest evidence base of any use here.

A 2026 Cochrane review looked at young children. Vitamin D probably does not reduce the proportion of children making healthcare visits for ARIs, where ARI is an acute respiratory infection, and does not reduce the mean number of ARI-related healthcare visits per child.

Safety was reassuring in the same review. Hypercalcaemia occurs infrequently in both pregnant women and children receiving it, hypercalcaemia meaning raised blood calcium, the main toxicity of concern.

The COVID question

Handled separately because it is asked separately, and because the answer is easy to misread.

An umbrella review found that low vitamin D levels are associated with higher infection rates, more severe disease, and higher mortality rates among people with COVID.

That is an association with a person’s level, not a result from giving them a supplement. Being ill lowers vitamin D, people who are indoors and unwell get less sun, and the sickest patients differ in many ways. The reviewers add the necessary warning themselves: the methodological quality of most meta-analyses and the level of evidence for most outcomes are very low.

What the evidence says about vitamin D and heart disease

Clean, large and negative.

A pooled analysis gathered nine trials, compromising 114 379 participants in the authors’ own phrasing. Against placebo, vitamin D did not reduce any CVD events, meaning cardiovascular ones, nor cardiovascular deaths, heart attacks, or deaths from heart attack.

Their conclusion needs no interpretation: current evidence does not support the use of vitamin D for the prevention of major cardiovascular events.

More than a hundred thousand people is enough to detect a benefit worth having. There was none.

What the evidence says about vitamin D and blood sugar

Here the picture splits by who is taking it, which is the most useful finding on the page.

A 2026 review of randomized trials in type 2 diabetes found supplementation consistently increased serum 25(OH)D levels, as it should. Blood sugar responded only partly: significant reductions in HbA1c and FBG were reported in approximately half of the studies. HbA1c is the three-month blood sugar average and FBG is fasting blood glucose.

The pattern inside that half is the point. The improvements concentrated particularly among participants with baseline vitamin D deficiency.

The authors state the conclusion this whole page keeps arriving at. Supplementation may improve glycemic control, meaning blood sugar management, in individuals with T2DM who are vitamin D deficient, but appears ineffective in those with sufficient levels, and so targeted supplementation based on individual vitamin D status is recommended, rather than universal administration.

What the evidence says about vitamin D and depression

A real effect that dissolves as you watch it, which is worth more than either a yes or a no.

A dose-response meta-analysis found a moderate reduction in depressive symptoms overall. Then it broke the trials down by how long they ran.

Trials of eight weeks or less showed a clear effect. Trials running 24 to 52 weeks showed almost nothing. Trials longer than 52 weeks pointed slightly the wrong way, and the difference between those groups was strong.

An effect that shrinks the longer you look for it is the classic signature of a fragile result, driven by short trials, early enthusiasm and people feeling better for reasons other than the capsule. It is not proof of nothing. It is a reason to be careful with the headline.

Anxiety got a flat answer: vitamin D3 supplementation had no significant effects on anxiety symptoms.

What the evidence says about vitamin D in pregnancy

Widely recommended, and the evidence is thinner than the recommendation suggests.

A 2025 review covering 40 trials and 9954 participants found no effect of vitamin D on the risk of preterm birth, small-for-gestational age, or low birth weight infants.

The reviewers make an unusual and pointed recommendation about what should happen next. Additional studies among the general pregnant population are not needed, given the many existing trials. What they call for instead is high-quality RCTs among populations with low vitamin D status, which is the same targeting argument as the diabetes section.

They also note that 25 trials had at least 1 domain at high risk of bias, so the existing evidence is not merely null but shaky.

What the evidence says about vitamin D and male fertility

A narrow use with a familiar shape: the markers move and the outcome does not.

A 2026 review in infertile men found vitamin D supplementation was associated with small but real improvements in semen volume, sperm concentration, progressive motility and serum testosterone.

Then the part that matters to anyone trying to conceive: no significant effects were observed on clinical pregnancy or live birth.

One practical detail worth carrying. Higher doses did not help more: doses above 4,000 IU a day do not appear to confer additional benefits.

What the evidence says about vitamin D and cancer

Mostly an association with blood levels rather than a result from supplements, and the distinction decides how much it is worth.

An umbrella review of bladder cancer found low serum vitamin D is consistently associated with increased bladder cancer risk, with levels above a threshold appearing somewhat protective.

But on the question a shopper is actually asking, it is explicit: evidence on dietary intake and supplementation remains inconclusive.

Low vitamin D accompanies poor health generally. Illness reduces time outdoors, obesity sequesters vitamin D in fat tissue, and both raise cancer risk independently. An association between a low reading and a diagnosis does not establish that raising the reading helps.

What the evidence says about vitamin D and the liver

One of the few places where a marker moved reliably.

A 2025 review in chronic liver disease found several liver enzymes were significantly reduced in the patients with vitamin D supplementation, along with triglycerides and insulin.

Two things keep it modest. The authors describe the effect as modest themselves. And the outcomes that would matter to a patient did not move: there were no differences in survival or in the two scan measures of liver fat and stiffness.

Better blood tests, same liver.

What the evidence says about vitamin D and cholesterol

Small, real, and confined to particular people.

A meta-analysis in women who were overweight or had obesity found vitamin D supplementation resulted in significant reductions in TG, meaning triglycerides, and in total cholesterol, with a small rise in the protective form.

The effect concentrated where there was more room to move: the reduction was larger in studies whose participants started with high triglycerides. And one number did not shift at all. Vitamin D has no significant effect on LDL-C concentrations, LDL-C being the harmful cholesterol that drives most treatment decisions.

What the evidence says about vitamin D and body composition

Frequently claimed, and this is close to a clean no.

A 2025 review in older adults found the vitamin D intake group was not associated with an increase in SMI, LM, or handgrip strength, where those are a muscle mass index, lean mass, and grip strength.

Fat mass showed a possible decrease, which sounds encouraging until you see what happened next. In the meta-analysis excluding studies that used active vitamin D, that finding disappeared too.

A result that survives only when a subgroup is left in is not a result to act on.

What the evidence says about vitamin D and inflammation

Included because it is the mechanism most often invoked for everything else, and because the answer is genuinely mixed rather than negative.

An umbrella review found reductions in inflammatory markers in some groups and not others. In type 2 diabetes, a significant reduction in hs-CRP and TNF-alpha appeared, both of them standard blood markers of inflammation, and oxidative stress markers improved in pregnant women.

But studies in obese/overweight and asthmatic populations revealed no significant changes in inflammatory markers.

Its summary is that vitamin D exerts significant anti-inflammatory and antioxidant effects, particularly in metabolic disorders, though evidence remains heterogeneous. These are laboratory readings, not symptoms, and they are reported here because the anti-inflammatory claim is used to sell the supplement for conditions the sections above have already answered.

What the evidence says about vitamin D and the gut

The newest and thinnest area on this page, included because the microbiome claim is now widely marketed.

A 2026 review of randomized trials found vitamin D does alter the gut microbiota, with specific alterations in microbial biomarkers such as calprotectin noted.

The reviewers immediately qualify it. The findings underscore the heterogeneity in study designs and methodologies, emphasizing the need for standardized approaches to assess causality and clinical relevance.

Nobody has shown that any of these shifts changes how a person feels or what illnesses they get. This is a research direction, not a reason to buy anything.

What the evidence says about vitamin D in kidney disease

A hospital use rather than a consumer one, and included because it is where deficiency is genuinely common.

A 2026 review in kidney transplant recipients found supplementation increased serum 25(OH)D levels and improved femoral neck bone mineral density. A hoped-for fall in parathyroid hormone did not reach significance.

It was done safely: the improvement was achieved safely without provoking hypercalcemia.

The reviewers’ bottom line is honest about how far it goes. Whether vitamin D supplementation improves post-transplant bone disease remains uncertain and requires further investigation. Anyone with kidney disease should be taking vitamin D only under specialist direction, because the kidney is where activation happens and the usual rules do not apply.

Myths about vitamin D, and what the evidence says

“It prevents fractures.” A 2026 BMJ review found little to no benefit for fractures or falls, largely at moderate to high certainty.

“It protects your heart.” Across 114,379 people in nine trials, no reduction in cardiovascular events, heart attacks or deaths.

“It stops you getting colds and flu.” In children, Cochrane found it probably does not reduce healthcare visits for respiratory infections.

“Low vitamin D causes disease.” Often the reverse. Illness keeps people indoors and obesity locks vitamin D away in fat tissue, so a low reading is frequently a consequence rather than a cause.

“More is better.” In the male fertility trials, doses above 4,000 IU a day added nothing. Because it is stored rather than excreted, high doses carry a real ceiling.

“Everyone is deficient.” Deficiency is genuinely common in specific groups, and that is exactly the point: the benefit belongs to them, not to everyone.

Dosing and forms of vitamin D

Doses are given in international units, abbreviated IU, or in micrograms. IU is the standard measure for a vitamin dose. Everyday supplements typically run from a few hundred to a few thousand IU a day.

Two forms are sold. D3, or cholecalciferol, is the form made in skin and the one used in most trials on this page. D2, or ergocalciferol, is plant-derived and generally regarded as less effective at raising blood levels.

The argument for testing before supplementing is stronger for vitamin D than for almost any other supplement, precisely because every section above found the benefit concentrated in people who were short. Without a test, a person taking it is guessing about the one thing that determines whether it will do anything.

Safety, side effects and who should be careful

At ordinary doses vitamin D is well tolerated, and the Cochrane review above found raised blood calcium occurred infrequently in children and pregnant women.

The risk is at the top end and it is real. Because it is stored in fat and liver rather than excreted, sustained very high intakes can raise blood calcium enough to cause nausea, confusion, kidney stones and kidney damage.

Particular caution applies to anyone with sarcoidosis or another granulomatous disease, where vitamin D processing is abnormal, and to anyone with kidney disease or a history of kidney stones.

Interactions

Vitamin D interacts with more medicines than its supermarket status suggests. Steroids, some cholesterol-lowering drugs, weight-loss drugs that block fat absorption, and some anti-seizure medicines all affect how it is absorbed or processed.

Because it raises calcium absorption, it also matters for anyone taking digoxin or thiazide diuretics, where a rise in calcium is not harmless.

Anyone on regular medication should check with a pharmacist rather than assume a vitamin is inert.

Bottom line on vitamin D

Thirteen areas of research, one answer repeated in each.

Vitamin D is genuinely essential, deficiency is genuinely common in identifiable groups, and correcting it in those groups is worth doing. What thirty years of trials have not found is a benefit from adding it on top of sufficiency, for bones, hearts, infections, moods, pregnancies or cancers.

That makes vitamin D unusual among supplements: not a myth, not a cure, and almost entirely a question of whether you are short of it. The test costs less than a year of capsules.